Current Liabilities
Total Current Liabilities
Gilead Sciences Total Current Liabilities decreased by 19.8% to $9.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.2%, from $12.34B to $9.48B. Over 5 years (FY 2020 to FY 2025), Total Current Liabilities shows relatively stable performance with a 0.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
How to read this metric
An increase suggests rising short-term obligations, which may strain liquidity if not matched by current asset growth.
Detailed definition
This is the aggregate sum of all financial obligations that the company is required to settle within one year or the cur...
Peer comparison
Universal metric for assessing short-term solvency across all industries.
Metric ID:
total_current_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.21B | $10.25B | $11.61B | $8.56B | $9.22B | $10.42B | $11.24B | $10.53B | $13.96B | $11.95B | $11.28B | $13.02B | $10.78B | $11.73B | $12.00B | $12.34B | $11.19B | $12.30B | $11.81B | $9.48B |
| QoQ Change | — | +0.3% | +13.3% | -26.3% | +7.7% | +13.0% | +7.8% | -6.3% | +32.6% | -14.5% | -5.6% | +15.4% | -17.2% | +8.8% | +2.4% | +2.8% | -9.4% | +9.9% | -3.9% | -19.8% |
| YoY Change | — | — | — | — | -9.7% | +1.7% | -3.2% | +23.0% | +51.5% | +14.6% | +0.4% | +23.6% | -22.8% | -1.8% | +6.4% | -5.2% | +3.8% | +4.9% | -1.6% | -23.2% |
Range$8.56B – $13.96B
CAGR-1.6%
Avg YoY Growth+3.9%
Median YoY Growth+1.1%
Current Streak2 quarters decline
Total Current Liabilities at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's total current liabilities?
- Gilead Sciences (GILD) reported total current liabilities of $9.48B in Q1 2026.
- How has Gilead Sciences's total current liabilities changed year-over-year?
- Gilead Sciences's total current liabilities decreased by 23.2% year-over-year, from $12.34B to $9.48B.
- What is the long-term trend for Gilead Sciences's total current liabilities?
- Over 5 years (2020 to 2025), Gilead Sciences's total current liabilities has grown at a 0.7% compound annual growth rate (CAGR), from $11.40B to $11.81B.
- What does total current liabilities mean?
- The total amount of all debts and obligations due within the next twelve months.